Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Universus Photo Imagings's Debt-to-Equity or its related term are showing as below:
During the past 11 years, the highest Debt-to-Equity Ratio of Universus Photo Imagings was -0.68. The lowest was -0.68. And the median was -0.68.
NSE:UNIVPHOTO's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.22 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Universus Photo Imagings Debt-to-Equity Related Terms
Universus Photo Imagings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNIVPHOTO vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Universus Photo Imagings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universus Photo Imagings Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Universus Photo Imagings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Universus Photo Imagings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universus Photo Imagings (NSE:UNIVPHOTO) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Universus Photo Imagings and its competitors. According to the industry distribution chart, Universus Photo Imagings ranks #999999 out of 702 companies in the Medical Devices & Instruments industry.
Is Universus Photo Imagings' Debt-to-Equity too high?
Universus Photo Imagings' current Debt-to-Equity is 0.00. Based on the distribution chart, Universus Photo Imagings ranks #999999 out of 702 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Universus Photo Imagings has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universus Photo Imagings' Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Universus Photo Imagings ranks #999999 out of 702 companies for Debt-to-Equity. This places Universus Photo Imagings in the lower half of its industry. The industry median Debt-to-Equity is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.22, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Universus Photo Imagings and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universus Photo Imagings's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universus Photo Imagings stock overvalued right now?
Based on GuruFocus' analysis, Universus Photo Imagings (NSE:UNIVPHOTO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹172.30, compared to a current price of ₹478.00 — trading 177.4% above its estimated fair value. The current Debt-to-Equity is 0.00. Universus Photo Imagings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Universus Photo Imagings (NSE:UNIVPHOTO), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universus Photo Imagings (NSE:UNIVPHOTO) Overvalued in 2026?
Based on GuruFocus' analysis, Universus Photo Imagings stock appears to be overvalued.
The current stock price of ₹478.00 is trading 177.4% above its estimated GF Value™ of ₹172.30.
GuruFocus considers Universus Photo Imagings to be Significantly Overvalued.
Key valuation signals for NSE:UNIVPHOTO:
Debt-to-Equity: 0.00
GF Value™: ₹172.30 vs. price of ₹478.00 (177.4% above fair value)
No single metric tells the full story. See the NSE:UNIVPHOTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universus Photo Imagings Ltd specializes in manufacturing, selling, distributing, converting, and producing X-ray films and NTR (non-toxic radiographic) films with matt and glossy finishes. These films are used for medical imaging and various photographic applications such as photo albums, certificates, playing cards, gift cards, visiting cards, calendars, menu cards, wedding cards, and modeling portfolios. The company operates a high-tech manufacturing facility located at Dadra in the Union Territory of Dadra and Nagar Haveli, India. Revenue is generated through the sale of these imaging products to medical and photographic industries.
53GF Score
Get the complete analysis for NSE:UNIVPHOTO
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIVPHOTO has been successfully added to your 
